Where am I?
© Fraunhofer CIMD
Development of a combined biomarker profile from innovative imaging data and liquid biopsy-based RNA analyses for early diagnosis in risk populations.
HuCIA: a humanized murine arthritis model for the development of innovative immunotherapeutics for rheumatoid arthritis.
© fotolia
Mucosal application of RSV antigens to prevent juvenile bronchial asthma.
Extracellular vesicles in rheumatoid arthritis.
Therapeutic Th17.1 cell modulation.
Development of an information system for the treatment of immune-mediated diseases.
Protecting patients with chronic lung diseases against respiratory viral infections by inhalation of interferon nanocapsules.
Development of a novel therapeutic concept for IBD via non-toxic ligands of the aryl hydrocarbon receptor.
© iStock.com | ktsimage
Diagnostics of immune diseases based on altered sugar structures.
Development of a rapid test system for early and care-relevant detection of immune-mediated musculoskeletal disorders.
Targeted investigations of the immune system in SARS-CoV-2 infections.
Development of an intelligent algorithm to assist in the early diagnosis of psoriatic arthritis and axial spondyloarthritis.
Specific alteration of the intestinal bacterial colonization for treatment of immune diseases.
Fraunhofer Cluster of Excellence Immune-Mediated Diseases